Vaccination Against GIP for the Treatment of Obesity
Author Information
Author(s): Fulurija Alma, Lutz Thomas A., Sladko Katja, Osto Melania, Wielinga Peter Y., Bachmann Martin F., Saudan Philippe
Primary Institution: Cytos Biotechnology AG, Schlieren, Switzerland
Hypothesis
Disrupting GIP signaling through vaccination may provide a novel therapeutic strategy for obesity treatment.
Conclusion
Vaccination against GIP was found to be safe and effective in reducing body weight gain in mice on a high fat diet.
Supporting Evidence
- Vaccination with VLP-GIP induced high titers of specific antibodies.
- Qβ-GIP vaccinated mice gained 35% less weight compared to controls.
- Body fat content was reduced by 28% in vaccinated mice.
- Vaccination did not affect glucose homeostasis in mice.
Takeaway
The study shows that a vaccine can help mice not gain as much weight when they eat a lot of fat, which might help people with obesity.
Methodology
Mice were vaccinated with GIP peptides attached to virus-like particles and monitored for body weight gain and antibody response.
Limitations
Further preclinical safety/toxicology studies are required before human trials can be considered.
Participant Demographics
C57BL/6 female mice, approximately 20 g, aged 8 weeks.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website